Working… Menu
Trial record 1 of 1 for:    NCT04085523
Previous Study | Return to List | Next Study

A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04085523
Recruitment Status : Enrolling by invitation
First Posted : September 11, 2019
Last Update Posted : November 3, 2020
Information provided by (Responsible Party):
Ascendis Pharma A/S

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : June 2023
Estimated Study Completion Date : June 2026